CRISPR activation screen identifies BCL-2 proteins and B3GNT2 as drivers of cancer resistance to T cell-mediated cytotoxicity
Julia Joung(Broad Institute), Feng Zhang(Broad Institute)
Cited by 113
Related Papers
Evolutionary classification of CRISPR–Cas systems: a burst of class 2 and derived variants
|Nature Reviews Microbiology|2019|2.5k
In vivo genome editing improves muscle function in a mouse model of Duchenne muscular dystrophy
|Science|2015|1.1k
Disease-associated astrocytes in Alzheimer’s disease and aging
|Nature Neuroscience|2020|1k